Zhang Yuzhou

Lung Function as a Biomarker for Glaucoma: The UK Biobank Study.

Lower FVC, FEV1, FEV1/FVC, and impaired lung function are potential biomarkers for glaucoma risk. These findings may facilitate clinical strategies for glaucoma management, particularly for individuals with impaired lung function.

Association between leukocyte telomere length and incident glaucoma: A prospective UK biobank study.

This study suggested that LTL is not a major biomarker for incident glaucoma in the UK Biobank population. Further studies in different populations are warranted.

Large-Scaled Proteomics Analysis for Glaucoma: Integrated Genetics, Multi-Omics, UK Biobank and Therapeutic Analysis.

Our findings provide new insights into the proteomic basis of glaucoma and highlight promising opportunities for developing targeted therapies.